Evidence map›Paper›PMID 32784746›Full record

ArticleDiseases (Basel, Switzerland)2020

Fosfomycin, Applying Known Methods and Remedies to A New Era.

Viviana Albán M, Estefanía Mariño-Brito, Fernando Villavicencio, Carolina Satán, José E Villacís, Mónica C Gestal

Open access · goldAbstract read
In one paragraph

Article in Diseases (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 69% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Viviana Albán MCentro de Referencia Nacional de Resistencia a los Antimicrobianos, Instituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez", Quito 170403, Ecuador.
Estefanía Mariño-BritoFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170143, Ecuador.
Fernando VillavicencioCentro de Referencia Nacional de Resistencia a los Antimicrobianos, Instituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez", Quito 170403, Ecuador.
Carolina SatánCentro de Referencia Nacional de Resistencia a los Antimicrobianos, Instituto Nacional de Investigación en Salud Pública "Leopoldo Izquieta Pérez", Quito 170403, Ecuador.ORCID 0000-0002-7637-7539
José E VillacísFacultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito 170143, Ecuador.ORCID 0000-0003-1478-5374
Mónica C GestalHealth Science Center, Louisiana State University (LSU), Shreveport, LA 71103, USA.ORCID 0000-0001-7417-2460
Instituto Nacional de Investigación en Salud Pública · ECPontificia Universidad Católica del Ecuador · ECLouisiana State University in Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exponential increase in the numbers of isolates of Carbapenem-Resistant

Indexed as

agar dilutioncarbapenem-resistant Enterobacteriaceae (CRE)disk diffusionfosfomycin

Identifiers

PMID32784746
PMCPMC7564589
OpenAlexW3047828981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.